Atrial septal defect: genes and variants
Explore variant evidence for Atrial septal defect across 9 analyzed proteins (NKX2-5, ACTC1, GATA4, TBX20, MYH6 and 4 more). Linked ClinVar records include 35 pathogenic or likely pathogenic variants, 470 variants of uncertain significance and 53 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Atrial septal defect
NKX2-5: Homeobox protein Nkx-2.5
It specifies myocardial lineages and maintains genes needed for adult conduction and contractile function. Heterozygous pathogenic variants can cause congenital heart defects, especially atrial septal defects, often with progressive conduction disease.
14 ClinVar pathogenic / likely pathogenic and 230 uncertain variants in NKX2-5 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
ACTC1: Actin, alpha cardiac muscle 1
Its cardiac alpha-actin filaments form the core of the sarcomeric thin filament and provide the track against which myosin generates force. Pathogenic variants can cause hypertrophic or dilated cardiomyopathy and selected congenital heart defects.
10 ClinVar pathogenic / likely pathogenic and 172 uncertain variants in ACTC1 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
GATA4: Transcription factor GATA-4
It controls cardiac development and adult cardiac gene expression and also contributes to gonadal and gastrointestinal development. Heterozygous pathogenic variants can cause congenital heart defects, particularly septal defects, and occasionally cardiomyopathy or disorders of sex development.
5 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in GATA4 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
TBX20: T-box transcription factor TBX20
It controls transcriptional programs required for cardiac chamber formation, septation, conduction-system development, and adult myocardial function. Heterozygous pathogenic variants can cause congenital heart defects and dilated cardiomyopathy.
2 ClinVar pathogenic / likely pathogenic and 23 uncertain variants in TBX20 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
MYH6: Myosin-6
Its alpha-myosin motor contributes to ATP-dependent force generation in the cardiac sarcomere, particularly in atrial myocardium. Pathogenic variants can cause cardiomyopathy, congenital heart defects, and selected conduction-system disorders.
1 ClinVar pathogenic / likely pathogenic and 77 uncertain variants in MYH6 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
ABCC8: ATP-binding cassette sub-family C member 8
It senses cellular nucleotide levels as the regulatory component of pancreatic beta-cell ATP-sensitive potassium channels and thereby couples glucose metabolism to insulin secretion. Loss-of-function variants cause congenital hyperinsulinism, whereas activating variants can cause neonatal diabetes.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABCC8 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
GATA6: Transcription factor GATA-6
It regulates developmental programs in the pancreas, heart, gut, and other endoderm-derived tissues. Haploinsufficiency is a major cause of pancreatic agenesis and neonatal diabetes and can also produce congenital heart disease and other developmental abnormalities.
0 ClinVar pathogenic / likely pathogenic and 10 uncertain variants in GATA6 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
TGFB2: Transforming growth factor beta-2 proprotein
Its secreted signaling regulates extracellular matrix, cell differentiation, proliferation, and cardiovascular development. Haploinsufficiency causes a Loeys-Dietz-spectrum connective-tissue disorder with increased risk of thoracic aortic aneurysm and dissection.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TGFB2 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
TPM1: Tropomyosin alpha-1 chain
It lies along actin filaments and helps control access of myosin to actin in response to troponin and calcium, while also stabilizing cytoskeletal actin in nonmuscle cells. Pathogenic variants can cause hypertrophic or dilated cardiomyopathy and several congenital myopathies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TPM1 have source records linked to Atrial septal defect. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CREBBP and TBX5.
Where Atrial septal defect variants cluster
- NKX2-5 Homeobox (positions 138–197): 11 of 14 ClinVar pathogenic / likely pathogenic variants, 4.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Atrial septal defect
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GATA4 R284H | 284 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| NKX2-5 L171P | 171 | Homeobox | Pathogenic / likely pathogenic (★★) |
| NKX2-5 T178M | 178 | Homeobox | Pathogenic / likely pathogenic (★★) |
| ACTC1 T128I | 128 | Pathogenic / likely pathogenic (★★) | |
| ACTC1 G247D | 247 | Pathogenic / likely pathogenic (★★) | |
| ACTC1 I289T | 289 | Pathogenic / likely pathogenic (★★) | |
| GATA4 R283H | 283 | GATA-type 2 | Pathogenic / likely pathogenic (★★) |
| ACTC1 R256C | 256 | Pathogenic / likely pathogenic (★) | |
| NKX2-5 F145L | 145 | Homeobox | Pathogenic / likely pathogenic (★) |
| NKX2-5 L153P | 153 | Homeobox | Pathogenic / likely pathogenic (★) |
| NKX2-5 Q181H | 181 | Homeobox | Pathogenic / likely pathogenic (★) |
| NKX2-5 R189G | 189 | Homeobox | Pathogenic / likely pathogenic (★) |
| NKX2-5 R190H | 190 | Homeobox | Pathogenic / likely pathogenic (★) |
| NKX2-5 Y191C | 191 | Homeobox | Pathogenic / likely pathogenic (★) |
| ACTC1 A333P | 333 | Pathogenic / likely pathogenic (★) | |
| NKX2-5 Q187H | 187 | Homeobox | Pathogenic / likely pathogenic (★) |
| NKX2-5 N188K | 188 | Homeobox | Pathogenic / likely pathogenic (★) |
| ABCC8 R598Q | 598 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★) |
| ACTC1 K52T | 52 | Pathogenic / likely pathogenic (★) | |
| ACTC1 I194N | 194 | Pathogenic / likely pathogenic (★) | |
| ACTC1 K317N | 317 | Pathogenic / likely pathogenic (★) | |
| GATA4 Y298C | 298 | Pathogenic / likely pathogenic (★) | |
| NKX2-5 Q22K | 22 | Pathogenic / likely pathogenic (★) | |
| TBX20 D176N | 176 | T-box | Pathogenic / likely pathogenic (★) |
| ACTC1 A297S | 297 | Pathogenic / likely pathogenic (★) | |
| NKX2-5 E154G | 154 | Homeobox | Pathogenic / likely pathogenic |
| MYH6 I820N | 820 | Pathogenic / likely pathogenic | |
| NKX2-5 K15I | 15 | Pathogenic / likely pathogenic | |
| TGFB2 P338T | 338 | Pathogenic / likely pathogenic | |
| TPM1 S229F | 229 | Coiled coil | Pathogenic / likely pathogenic |
| GATA4 S52F | 52 | Pathogenic / likely pathogenic | |
| GATA4 G296C | 296 | Pathogenic / likely pathogenic | |
| TBX20 I121M | 121 | T-box | Pathogenic / likely pathogenic |
| ACTC1 M125V | 125 | Pathogenic / likely pathogenic | |
| NKX2-5 D299G | 299 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Atrial septal defect
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| ACTC1 A333V | 333 | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (3R); A333P at the same position is pathogenic; REVEL 0.919 | |
| NKX2-5 L153V | 153 | Homeobox | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; L153P at the same position is pathogenic; REVEL 0.903 |
| NKX2-5 Q187E | 187 | Homeobox | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; Q187H at the same position is pathogenic; REVEL 0.960 |
| NKX2-5 L171Q | 171 | Homeobox | Uncertain (★) | +6: L171P at the same position is pathogenic; REVEL 0.975 |
| NKX2-5 N188T | 188 | Homeobox | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; N188K at the same position is pathogenic; REVEL 0.936 |
| NKX2-5 R189W | 189 | Homeobox | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; REVEL 0.903 |
| NKX2-5 R189P | 189 | Homeobox | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; REVEL 0.960 |
| NKX2-5 R189Q | 189 | Homeobox | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; REVEL 0.912 |
| NKX2-5 R190C | 190 | Homeobox | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; R190H at the same position is pathogenic; REVEL 0.950 |
Which prediction tools work for Atrial septal defect
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- VARITY: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- EVE: 88 out of 100
- SIFT: 87 out of 100
- phastCons: 82 out of 100
- PolyPhen-2: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 64 out of 100
Same protein, different disease
- Atrioventricular septal defect also has ClinVar records linked to GATA4 variants; they fall partly in the same places as the Atrial septal defect variants (7 pathogenic / likely pathogenic).
- Heart disease also has ClinVar records linked to GATA4 variants; they fall mostly in different places as the Atrial septal defect variants (4 pathogenic / likely pathogenic).
- Hypertrophic cardiomyopathy also has ClinVar records linked to TPM1 variants; they fall mostly in different places as the Atrial septal defect variants (15 pathogenic / likely pathogenic).
- Primary dilated cardiomyopathy also has ClinVar records linked to TPM1 variants; they fall mostly in different places as the Atrial septal defect variants (6 pathogenic / likely pathogenic).
- Dilated cardiomyopathy also has ClinVar records linked to TPM1 variants; they fall mostly in different places as the Atrial septal defect variants (6 pathogenic / likely pathogenic).
- Loeys-Dietz syndrome also has ClinVar records linked to TGFB2 variants; they fall mostly in different places as the Atrial septal defect variants (6 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to TGFB2 variants; they fall mostly in different places as the Atrial septal defect variants (5 pathogenic / likely pathogenic).
Diseases related to Atrial septal defect
- Hypertrophic cardiomyopathy, also linked to ACTC1, MYH6 and TPM1
- Dilated cardiomyopathy, also linked to ACTC1, TBX20 and TPM1
- Primary dilated cardiomyopathy, also linked to ACTC1, MYH6 and TPM1
- Familial isolated dilated cardiomyopathy, also linked to ACTC1, MYH6 and TPM1
- Monogenic diabetes, also linked to ABCC8 and GATA6
- Heart disease, also linked to GATA4 and NKX2-5
- Left ventricular noncompaction, also linked to ACTC1 and TPM1
- Atrioventricular septal defect, also linked to GATA4 and GATA6
- Ventricular septal defect, also linked to GATA4 and NKX2-5
- Hypoplastic left heart syndrome, also linked to MYH6 and NKX2-5
- Familial thoracic aortic aneurysm and aortic dissection, also linked to TGFB2
- Ehlers-Danlos syndrome, also linked to TGFB2
Frequently asked questions
Which genes have records linked to Atrial septal defect?
This view contains 9 analyzed proteins: NKX2-5, ACTC1, GATA4, TBX20, MYH6 and 4 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 35 pathogenic or likely pathogenic variants, 470 variants of uncertain significance and 53 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 614 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center